Vimarsana
Biggest News Aggregation in the World

Shintaro Kanda News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Shintaro Kanda. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Shintaro Kanda Today - Breaking & Trending Today

Chemotherapy after first-line EGFR TKI fails to extend survival in advanced NSCLC - Vimarsana News

Chemotherapy after first-line EGFR TKI fails to extend survival in advanced NSCLC

CHICAGO — Platinum-doublet chemotherapy did not extend survival for patients with advanced nonsquamous non-small cell lung cancer who responded to EGFR tyrosine kinase inhibitor therapy, according to randomized phase 3 study results.The regimen prolonged PFS but did not confer an OS benefit, findings presented at ASCO Annual Meeting showed.

Source: healio.com